Sonoma Pharmaceuticals (SNOA) Revenue Growth (3y) (2013 - 2026)
Sonoma Pharmaceuticals (SNOA) Revenue Growth (3y) (2013 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 89.01 Bn | 87.15 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 35.89 Bn | 32.15 Bn | 1.97 Bn | 2.84% |
| 3 | Zoetis | 32.48 Bn | 30.54 Bn | 1.62 Bn | 4.19% |
| 4 | Takeda Pharmaceutical | 27.52 Bn | 23.46 Bn | 4.39 Bn | -4.46% |
| 5 | United Therapeutics | 23.14 Bn | 20.99 Bn | 648.10 Mn | 15.52% |
| 6 | RedHill Biopharma | 21.76 Bn | 21.76 Bn | - | - |
| 7 | Viatris | 20.35 Bn | 18.55 Bn | 1.16 Bn | -2.00% |
| 8 | Neurocrine Biosciences | 17.73 Bn | 16.41 Bn | 800.70 Mn | 24.66% |
| 9 | Elanco Animal Health | 12.56 Bn | 12.14 Bn | 785.00 Mn | 2.94% |
| 10 | Sonoma Pharmaceuticals | 1.92 Mn | -479,240.02 | 2.18 Mn | 22.65% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 22.65% |
| Dec 31, 2025 | 13.89% |
| Sep 30, 2025 | 18.93% |
| Jun 30, 2025 | 0.27% |
| Mar 31, 2025 | 17.77% |
| Dec 31, 2024 | 7.09% |
| Sep 30, 2024 | -1.49% |
| Jun 30, 2024 | -2.72% |
| Mar 31, 2024 | 16.82% |
| Dec 31, 2023 | -14.01% |
| Sep 30, 2023 | -22.06% |
| Jun 30, 2023 | -15.93% |
| Mar 31, 2023 | -11.25% |
| Dec 31, 2022 | -12.50% |
| Sep 30, 2022 | -11.01% |
| Jun 30, 2022 | -3.95% |
| Mar 31, 2022 | -19.36% |
| Dec 31, 2021 | -18.09% |
| Sep 30, 2021 | -8.82% |
| Jun 30, 2021 | -5.53% |